Product Description: Thymocartin TFA is the TFA salt form of Thymocartin (HY-105025). Thymocartin TFA inhibits apoptosis of peripheral blood lymphocytes in HIV infected individuals. Thymocartin TFA is potential for immunodeficiency diseases research[1][2].
Applications: COVID-19-immunoregulation
Formula: C21H40N8O7.xC2HF3O2
References: [1]la Szende B, et al., Reduction of apoptosis of in vitro cultured peripheral blood lymphocytes of HIV positive individuals by thymocartin[J]. Medical Science Monitor, 1997, 3(4): BR456-BR459./[2] S Lang, et al. Transport and metabolic pathway of thymocartin (TP4) in excised bovine nasal mucosa. J Pharm Pharmacol. 1996 Nov;48(11):1190-6.
Molecular Weight: 516.59 (free acid)
Compound Purity: 99.56
Research Area: Inflammation/Immunology
Target: Apoptosis